S41467-020-20078-3.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Venom Back in Vogue As a Wellspring for Drug Candidates How a New Wave of Research on Venoms from an Array of Creatures Could Seed Future Pharma Development
NEWS FEATURE NEWS FEATURE Venom back in vogue as a wellspring for drug candidates How a new wave of research on venoms from an array of creatures could seed future pharma development. Amy McDermott, Science Writer Pediatric neurosurgeon Amy Lee works by the small, in real time, how much tumor they’ve removed, and bright light of a microscope, her gaze focused on the how much is left behind. opened skull of a child. Lee moves her hands calmly That green glow comes from tozuleristide, a new and confidently over the exposed brain, plucking diagnostic drug in phase two clinical trials. But the out as much tumor as she safely can. drug’s novelty stems not only from its potential to high- But there are some surgeries, and some parts of light troublesome childhood tumors, but also from the the brain, where tumor tissue and healthy tissue look compound’s source: the potent venom of the Israeli very much alike. In those cases, Lee, based at Seattle deathstalker scorpion (Leiurus quinquestriatus). Children’s Hospital in Washington, looks to a com- Tozuleristide uses a peptide from the venom and puter monitor beside the operating table, where a an infrared dye to seek out and illuminate tumors of view of the brain shows tumor, illuminated in fluores- all kinds, including in the breast, colon, and skin. The cent green, nestled in otherwise white, healthy tis- drug has gone through safety testing and early clinical sue. This new diagnostic tool helps surgeons gauge, trials to image brain tumors in children, and today A handful of promising new drug candidates are derived from peptides in the venom of scorpions and other animals. -
(Scorpiones: Buthidae) Venom a Thesis Submitted
PEPTIDOMIC CHARACTERIZATION AND BIOACTIVITY SCREENING OF LEIURUS ABDULLAHBAYRAMI (SCORPIONES: BUTHIDAE) VENOM A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNICAL UNIVERSITY BY EFE ERDEŞ IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN BIOTECHNOLOGY JANUARY 2015 Approval of the thesis: PEPTIDOMIC CHARACTERIZATION AND BIOACTIVITY SCREENING OF LEIURUS ABDULLAHBAYRAMI (SCORPIONES: BUTHIDAE) VENOM submitted by EFE ERDEŞ in partial fulfillment of the requirements for the degree of Master of Science in Biotechnology Department, Middle East Technical University by, Prof. Dr. Gülbin Dural Ünver _______________ Dean, Graduate School of Natural and Applied Sciences Prof. Dr. Filiz Bengü Dilek _______________ Head of Department, Biotechnology Assoc. Prof. Dr. Can Özen _______________ Supervisor, Biotechnology Department, METU Assoc. Prof. Dr. Mayda Gürsel _______________ Co-supervisor, Biology Department, METU Examining Committee Members: Prof. Dr. Halit Sinan Süzen _______________ Faculty of Pharmacy, Ankara University Assoc. Prof. Dr. Can Özen _______________ Biotechnology Department, METU Assoc. Prof. Dr. Çağdaş Devrim Son _______________ Biology Department, METU Assist. Prof. Dr. Salih Özçubukçu _______________ Chemistry Department, METU Dr. Tamay Şeker _______________ Central Laboratory, METU Date: 16.01.2015 I hereby declare that all information in this document has been obtained and presented in accordance with academic rules and ethical conduct. I also declare that, as required by these rules and conduct, I have fully cited and referenced all material and results that are not original to this work. Name, Last name: Efe ERDEŞ Signature : iv ABSTRACT PEPTIDOMIC CHARACTERIZATION AND BIOACTIVITY SCREENING OF LEIURUS ABDULLAHBAYRAMI (SCORPIONES: BUTHIDAE) VENOM Erdeş, Efe M.S., Department of Biotechnology Supervisor: Assoc. -
Fauna and Flora of South Sinai
PART II. – Fauna and flora of South Sinai Francis Gilbert & Samy Zalat South Sinai is one of three richest places in Egypt for biodiversity, the others being the Mediterranean coast and Gebel Elba in the extreme south west. The reason is simple: water. Although visitors may be forgiven for their disbelief, these places have by far the highest and the most reliable precipitation, in the form of rain, snow (in South Sinai) or fog (in Gebel Elba). This section provides a miscellany of the common kinds of animals and plants that live in South Sinai, together with some of the more interesting rarer types. Some have a very restricted distribution and are priority species for conservation. The species are grouped taxonomically, and according to the size, colour, defence or status as a resident or migrant. There are brief notes to introduce each group. The brief account of each species starts with the common and the scientific names, the South Sinai Bedouin (rather than general Arabic) name, and our best understanding of its conservation status (following IUCN categories). Where possible there is a photograph with the notes of interest about the species. A few of the photographs are not of a specimen in South Sinai, but the vast majority are. Information specific to South Sinai about these animals is hard to find since it is scattered in many obscure journals and books. It is easier to look at Egypt as a whole. The following websites and books will help expand on the information presented here, and contain bibliographies to enable you to go further: Egypt’s biodiversity: http://www.biomapegypt.org/biodiversity/index.html General information: http://www.biomapegypt.org/ Research we have done: http://www.nottingham.ac.uk/~plzfg/ Baha El Din SM (2005) A guide to the reptiles and amphibians of Egypt. -
Scorpion) Venom in Different Human Cancer Cell Lines in Vitro
Salama & El-Naggar Tropical Journal of Pharmaceutical Research February 2021; 20 (2): 345-350 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v20i2.18 Original Research Article Cytotoxic effect of Leurius quinquestratus (scorpion) venom in different human cancer cell lines in vitro Wesam M Salama*, Sabry A El-Naggar Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt *For correspondence: Email: [email protected]; Tel: +20-01200355329 Sent for review: 18 August 2020 Revised accepted: 18 January 2021 Abstract Purpose: In this study, the cytotoxicity of scorpion Leurius quinquestratus crude venom (LQCV) was evaluated in vitro in selected human cancer cell lines. Methods: Breast (MCF-7), hepatocellular (HepG-2), colon (CaCo-2), cervix (HeLa) and alveolar (A-549) adenocarcinoma cell lines were tested. MTT assay and median inhibition concentration (IC50), apoptotic assay, caspase 3, P53, Bcl-2 proteins and cell cycle were determined. Results: 24 hrs post-treatment, CaCo-2 represented the most sensitive cell line (IC50 of 4.12 µg/mL). Due to the exposure to 1/10 IC50 of LQCV, the percentage of the apoptotic cells, caspase 3, and P53 proteins were increased significantly (P<0.05) while Bcl-2 was decreased in comparison to untreated cells. Treatment with LQCV induced cell cycle arrest at G1 and G2/M phases. Conclusion: LQCV displays potent cytotoxicity against selected human cell lines in vitro. Thus, the material could become a potent agent for the management of some cancers. -
Biotechnological Trends in Spider and Scorpion Antivenom Development
toxins Review Biotechnological Trends in Spider and Scorpion Antivenom Development Andreas Hougaard Laustsen 1,2,*, Mireia Solà 1, Emma Christine Jappe 1, Saioa Oscoz 1, Line Præst Lauridsen 1 and Mikael Engmark 1,3 1 Department of Biotechnology and Biomedicine, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark; [email protected] (M.S.); [email protected] (E.C.J.); [email protected] (S.O.); [email protected] (L.P.L.); [email protected] (M.E.) 2 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen East, Denmark 3 Department of Bio and Health Informatics, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark * Correspondence: [email protected]; Tel.: +45-2988-1134 Academic Editor: Nicholas R. Casewell Received: 14 June 2016; Accepted: 13 July 2016; Published: 23 July 2016 Abstract: Spiders and scorpions are notorious for their fearful dispositions and their ability to inject venom into prey and predators, causing symptoms such as necrosis, paralysis, and excruciating pain. Information on venom composition and the toxins present in these species is growing due to an interest in using bioactive toxins from spiders and scorpions for drug discovery purposes and for solving crystal structures of membrane-embedded receptors. Additionally, the identification and isolation of a myriad of spider and scorpion toxins has allowed research within next generation antivenoms to progress at an increasingly faster pace. In this review, the current knowledge of spider and scorpion venoms is presented, followed by a discussion of all published biotechnological efforts within development of spider and scorpion antitoxins based on small molecules, antibodies and fragments thereof, and next generation immunization strategies. -
Scorpiology with Dr. Lauren Esposito: Encore Presentation Ologies Podcast December 21, 2020
Scorpiology with Dr. Lauren Esposito: Encore Presentation Ologies Podcast December 21, 2020 2020 Alie: Just a quick note up top: This Scorpiology interview originally aired a year-and-a-half ago. But thanks to a very kind and generous write up about Ologies in this week’s New Yorker Magazine, (what!) I wanted to give it an encore, because the article’s author, Rachel Syme, said that this was the episode that got her hooked. So if you’re here because of the New Yorker, Hi! Hello. If you have already heard this episode, I promise it’s worth a re-listen because it really is chock-a- block full of weird facts. And Dr. Esposito made a return appearance, and gives us some updates about her life, as well as has a message for Ologies listeners. So, here we go. 2019 Alie: Oh heeey, it’s the lady in front of you at the checkout with 26 items, who doesn’t realize she’s in the express lane, and is fully oblivious to your glares, Alie Ward, back with another episode of Ologies. So, congrats for not skipping this one. You did it. If it’s on auto-play and you’re like, “NOOoOooOoO, don’t play the scorpion one.” It’s too late, bitch. It’s playing. You’re in this now. Don’t press stop. Don’t! This one is amazing. I promise there are facts in this episode that you will drop in conversation and it will make you un-fucking-forgettable. Okay, first, really quick, thank you patrons for making this show possible via Patreon.com/Ologies. -
Mast Cell Chymase Reduces the Toxicity of Gila Monster Venom, Scorpion Venom, and Vasoactive Intestinal Polypeptide in Mice
Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice Mitsuteru Akahoshi, … , Mindy Tsai, Stephen J. Galli J Clin Invest. 2011;121(10):4180-4191. https://doi.org/10.1172/JCI46139. Research Article Immunology Mast cell degranulation is important in the pathogenesis of anaphylaxis and allergic disorders. Many animal venoms contain components that can induce mast cell degranulation, and this has been thought to contribute to the pathology and mortality caused by envenomation. However, we recently reported evidence that mast cells can enhance the resistance of mice to the venoms of certain snakes and that mouse mast cell–derived carboxypeptidase A3 (CPA3) can contribute to this effect. Here, we investigated whether mast cells can enhance resistance to the venom of the Gila monster, a toxic component of that venom (helodermin), and the structurally similar mammalian peptide, vasoactive intestinal polypeptide (VIP). Using 2 types of mast cell–deficient mice, as well as mice selectively lacking CPA3 activity or the chymase mouse mast cell protease-4 (MCPT4), we found that mast cells and MCPT4, which can degrade helodermin, can enhance host resistance to the toxicity of Gila monster venom. Mast cells and MCPT4 also can limit the toxicity associated with high concentrations of VIP and can reduce the morbidity and mortality induced by venoms from 2 species of scorpions. Our findings support the notion that mast cells can enhance innate defense by degradation of diverse animal toxins and that release of MCPT4, in addition to CPA3, can contribute to this mast cell function. Find the latest version: https://jci.me/46139/pdf Research article Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice Mitsuteru Akahoshi,1 Chang Ho Song,1,2 Adrian M. -
Spiders, Scorpions, Horseshoe Crabs
Journal of Translational Science Review Article ISSN: 2059-268X Exploring the global animal biodiversity in the search for new drugs – Spiders, scorpions, horseshoe crabs, sea spiders, centipedes, and millipedes Dennis RA Mans* Department of Pharmacology, Faculty of Medical Sciences, Anton de Kom University of Suriname, Paramaribo, Suriname Abstract Drug discovery and development programs have historically mainly focused on plants with medicinal properties and the extensive knowledge of traditional healers about these plants. More recently, the vast array of marine invertebrates and insects throughout the world have been recognized as additional sources for identifying unusual lead compounds to obtain structurally novel and mechanistically unique therapeutics. The results from these efforts are encouraging and have yielded a number of clinically useful drugs. However, many arthropods other than insects - such as spiders, scorpions, horseshoe crabs, sea spiders, centipedes, and millipedes - also produce hundreds of bioactive substances in their venom that may become useful in the clinic. Many of these chemicals are defensive and predatory weapons of these creatures and have been refined during millions of years of evolution to rapidly and with high specificity and high affinity shut down critical molecular targets in prey and predators. Exploration of these compounds may lead to the development of, among others, novel drugs for treating diseases caused by abnormalities in humans in the same (evolutionary conserved) molecular targets such as erectyle dysfunction, botulism, and autoimmune disorders, as well as the identification of novel antineoplastic, antimicrobial, and antiparasitic compounds. This paper addresses the importance of bioactive compounds from spiders, scorpions, horseshoe crabs, sea spiders, centipedes, and millipedes to these advances. -
Venom Back in Vogue As a Wellspring for Drug Candidates
NEWS FEATURE Venom back in vogue as a wellspring for drug candidates NEWS FEATURE How a new wave of research on venoms from an array of creatures could seed future pharma development. Amy McDermott, Science Writer Pediatric neurosurgeon Amy Lee works by the in real time, how much tumor they’ve removed, and small, bright light of a microscope, her gaze fo- how much is left behind. cused on the opened skull of a child. Lee moves That green glow comes from tozuleristide, a new her hands calmly and confidently over the ex- diagnostic drug in phase two clinical trials. But the posed brain, plucking out as much tumor as she drug’s novelty stems not only from its potential to high- safely can. light troublesome childhood tumors, but also from the But there are some surgeries, and some parts of compound’s source: the potent venom of the Israeli the brain, where tumor tissue and healthy tissue look deathstalker scorpion (Leiurus quinquestriatus). very much alike. In those cases, Lee, based at Seattle Tozuleristide uses a peptide from the venom and Children’s Hospital in Washington, looks to a com- an infrared dye to seek out and illuminate tumors of puter monitor beside the operating table, where a all kinds, including in the breast, colon, and skin. The view of the brain shows tumor, illuminated in fluores- drug has gone through safety testing and early clinical cent green, nestled in otherwise white, healthy tis- trials to image brain tumors in children, and today sue. This new diagnostic tool helps surgeons gauge, stands about two years from possible US Food and A handful of promising new drug candidates are derived from peptides in the venom of scorpions and other animals. -
Scorpion Toxins Applications
Available online on www.ijtpr.com International Journal of Toxicological and Pharmacological Research 2012; 4(3): 57-61 ISSN: 0975-5160 Review Article Scorpion Toxins and its Applications *Baby Joseph, Jency George Interdisciplinary Research Centre, Department of Biotechnology, Malankara Catholic College, Mariagiri, Kaliakkavilai, Tamil Nadu, India ABSTRACT Scorpion venoms consist of neurotoxins. Animal venom and toxins are the potential bioresource and therapeutic tool in biomedical applications. Chinese, believing scorpion venom have powerful analgesic properties. Scorpion venom has been used as traditional and folk therapy in various pathophysiological conditions. Scorpion venom is a complex mixture of salts, neurotoxins, peptides and proteins. Scorpion toxins have antiproliferative, cytotoxic, apoptogenic, and immunosuppressive properties. These properties make scorpion toxin as useful agents for therapeutic application. This article reviews focused on the application of scorpion toxins in therapeutic and agriculture Keywords: Antiepileptic, Analgesic, Glioma, Scorpion toxins. INTRODUCTION normal cells along with cancer cells. The search for Medical applications of venoms and toxins have been cancer cure from natural product has been practiced for mentioned in Ayurvedic, unani, chineese and over a century. Scorpion toxins have shown therapeutic homeopathic system of medicine (1). Venom is the potential against cancer. secretary product of venomous animals. Venoms are Scorpion toxin for glioma: A glioma is a type of tumor in complex mixture of number of proteins, peptides, the brain or spine. The most common site of gliomas is enzymes, toxins and non protein inclusions. Toxins are the brain (4). It is called a glioma because it arises from chemically pure toxic substances. Scorpion toxins exhibit glial cells. The scorpion toxins are used to treat cancer a wide range of biological properties and actions. -
Pdf (377.01 K)
Vol. 12 No. 2 (2020) Vol. Vol. 12Vol. 13 No. No.12 2 No. (204 (2020220 (20) 20) ) Citation: Egypt. Acad. J. Biolog. Sci. (A. Entomology) Vol. 13(4) pp.199-211 (2020) Egypt. Acad. J. Biolog. Sci., 13(4):199-211(2020) Egyptian Academic Journal of Biological Sciences A. Entomology ISSN 1687- 8809 http://eajbsa.journals.ekb.eg/ Toxicity and Deleterious Impacts of the Deathstalker Scorpion, Leiurus quinquestriatus, Venom on Development of the Greater Wax Moth, Galleria mellonella (Lepidoptera: Pyralidae) Ghoneim, K.*; Hamadah, Kh.; Tanani, M. and Emam, D. Department of Zoology and Entomology, Faculty of Science, Al-Azhar University, Cairo, Egypt *Corresponding author: E.mail: [email protected] ARTICLE INFO ABSTRACT Article History The greater wax moth, Galleria mellonella L. (Lepidoptera: Received:7/9/2020 Pyralidae) is the most destructive pest of the honey bee, Apis mellifera, Accepted:28/11/2020 throughout the world. The current study was carried out to evaluate the Keywords: toxicity and disruptive effects of the venom of deathstalker scorpion, Adult, desiccation, Leiurus quinquestriatus (Buthidae: Scorpiones) on the growth, rd larva, development, and metamorphosis of this pest. The newly moulted 3 metamorphosis, instar larvae were fed on an artificial diet treated with a series of venom concentrations (250, 500, 1000, 2000, 4000, and 8000 ppm). The present morphogenesis, results could be summarized as follows. The venom exhibited mortality, pupation, considerable toxicity against larvae. Also, the pupae suffered a lethal survival. action of the venom, in a dose-dependent course. In contrast, adult survival was not affected by the tested venom. The LC50 was calculated in 3428.9 ppm. -
Biotechnological Trends in Spider and Scorpion Antivenom Development
Biotechnological Trends in Spider and Scorpion Antivenom Development Laustsen, Andreas Hougaard; Solà, Mireia; Jappe, Emma Christine; Oscoz Cob, Saioa; Lauridsen, Line; Engmark, Mikael Published in: Toxins DOI: 10.3390/toxins8080226 Publication date: 2016 Document version Publisher's PDF, also known as Version of record Citation for published version (APA): Laustsen, A. H., Solà, M., Jappe, E. C., Oscoz Cob, S., Lauridsen, L., & Engmark, M. (2016). Biotechnological Trends in Spider and Scorpion Antivenom Development. Toxins, 8(8), 1-33. [226]. https://doi.org/10.3390/toxins8080226 Download date: 26. Sep. 2021 toxins Review Biotechnological Trends in Spider and Scorpion Antivenom Development Andreas Hougaard Laustsen 1,2,*, Mireia Solà 1, Emma Christine Jappe 1, Saioa Oscoz 1, Line Præst Lauridsen 1 and Mikael Engmark 1,3 1 Department of Biotechnology and Biomedicine, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark; [email protected] (M.S.); [email protected] (E.C.J.); [email protected] (S.O.); [email protected] (L.P.L.); [email protected] (M.E.) 2 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen East, Denmark 3 Department of Bio and Health Informatics, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark * Correspondence: [email protected]; Tel.: +45-2988-1134 Academic Editor: Nicholas R. Casewell Received: 14 June 2016; Accepted: 13 July 2016; Published: 23 July 2016 Abstract: Spiders and scorpions are notorious for their fearful dispositions and their ability to inject venom into prey and predators, causing symptoms such as necrosis, paralysis, and excruciating pain.